Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Pol
2. E-in-7
3. 2923356-52-7
4. (3ar,11as)-6,10-dimethyl-1-(6-methyl-4-(trifluoromethyl)pyridin-2-yl)-5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3a,4,5,10,11a-hexahydro-2h-benzo[b]pyrrolo[2,3-f][1,4]diazocine-2,11(3h)-dione
5. Orb2945952
6. Schembl26444358
7. Art6043
8. Bdbm708819
9. Art-6043
10. Ex-a16349
11. Nsc856500
12. Nsc-856500
13. Us20240425511, Example 1
14. Hy-153755
| Molecular Weight | 544.6 g/mol |
|---|---|
| Molecular Formula | C28H35F3N6O2 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 63.2 |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 897 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
57
PharmaCompass offers a list of ART6043 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right ART6043 manufacturer or ART6043 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred ART6043 manufacturer or ART6043 supplier.
A ART6043 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ART6043, including repackagers and relabelers. The FDA regulates ART6043 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ART6043 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ART6043 supplier is an individual or a company that provides ART6043 active pharmaceutical ingredient (API) or ART6043 finished formulations upon request. The ART6043 suppliers may include ART6043 API manufacturers, exporters, distributors and traders.
ART6043 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ART6043 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right ART6043 GMP manufacturer or ART6043 GMP API supplier for your needs.
A ART6043 CoA (Certificate of Analysis) is a formal document that attests to ART6043's compliance with ART6043 specifications and serves as a tool for batch-level quality control.
ART6043 CoA mostly includes findings from lab analyses of a specific batch. For each ART6043 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ART6043 may be tested according to a variety of international standards, such as European Pharmacopoeia (ART6043 EP), ART6043 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ART6043 USP).
